(Hypertension. 1999;33:1441-1446.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Effect of Ceramide on KCa Channel Activity and Vascular Tone in Coronary Arteries
From the Departments of Pharmacology and Toxicology and Physiology, Medical College of Wisconsin, Milwaukee.
Abstract—A sphingomyelin metabolite, ceramide, serves as a second messenger in a variety of mammalian cells. Little is known regarding the production and actions of this novel intracellular signaling lipid molecule in the vasculature. The present study was designed to test the hypothesis that a ceramide-mediated signaling pathway is present in coronary arterial smooth muscle and that ceramide serves as an inhibitor of the large-conductance Ca2+-activated potassium (KCa) channels and mediates vasoconstriction in coronary circulation. We found that C2-ceramide produced a concentration-dependent decrease in KCa channel activity in vascular smooth muscle cells from small bovine coronary arteries. The average channel activity of the KCa channels in cell-attached patches decreased from 0.046±0.01 to 0.008±0.001 at a C2-ceramide concentration of 10 µmol/L. In inside-out patches, C2-ceramide (1 µmol/L) reduced the average channel activity of the KCa channels from 0.06±0.007 to 0.016±0.004. Dithiothreitol, an inhibitor of acidic sphingomyelinase (1 mmol/L), increased the average channel activity of the KCa channels in cell-attached patches from 0.05±0.02 of control to 0.26±0.04, a 5-fold increase that was reversed by addition of 1 µmol/L ceramide. Glutathione, an inhibitor of neutral sphingomyelinase, was without effect. C2-ceramide significantly reduced the diameter of isolated perfused small coronary arteries in a concentration-dependent manner. Addition of 1 µmol/L C2-ceramide decreased average arterial diameter by 28%. When 14C-sphingomyelin was incubated with coronary arterial homogenates at pH 7.4 and pH 5.0, 14C–choline phosphate and ceramide were produced. The conversion rates of 14C-sphingomyelin into 14C–choline phosphate and ceramide were 65.1±1.0 fmol/min per milligram protein at pH 7.4 and 114.6±8.3 fmol/min per milligram protein at pH 5.0. We conclude that both acidic and neutral sphingomyelinases are present in the bovine coronary arteries and that ceramide inactivates the KCa channel in arterial smooth muscle cells and hence exerts a tonic vasoconstrictor action in coronary microcirculation.
Key Words: sphingomyelinase • sphingolipid • muscle, smooth, vascular • potassium channels • heart
This article has been cited by other articles:
 |
|
 |
|
  H.-F. Bao, Z.-R. Zhang, Y.-Y. Liang, J. J. Ma, D. C. Eaton, and H.-P. Ma Ceramide mediates inhibition of the renal epithelial sodium channel by tumor necrosis factor-{alpha} through protein kinase C Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1178 - F1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chapman, C. Ramstrom, L. Korhonen, M. Laine, K. T. Wann, D. Lindholm, M. Pasternack, and K. Tornquist Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation J. Cell Sci., November 15, 2005; 118(22): 5325 - 5334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Zhang, Y.-F. Chen, D. X. Zhang, F.-X. Yi, J. Qi, P. Andrade-Gordon, L. de Garavilla, P.-L. Li, and A.-P. Zou Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F792 - F798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Constable, G. W. Smith, G. E. Rottinghaus, M. E. Tumbleson, and W. M. Haschek Fumonisin-induced blockade of ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2034 - H2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Sheu and S.-N. Wu Mechanism of Inhibitory Actions of Oxidizing Agents on Calcium-Activated Potassium Current in Cultured Pigment Epithelial Cells of the Human Retina Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1237 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. X. Zhang, F.-X. Yi, A.-P. Zou, and P.-L. Li Role of ceramide in TNF-alpha -induced impairment of endothelium-dependent vasorelaxation in coronary arteries Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1785 - H1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y H Zhang, M R Vasko, and G D Nicol Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+ current and delayed rectifier K+ current in rat sensory neurons J. Physiol., October 15, 2002; 544(2): 385 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-N. Wu, Y.-K. Lo, B. I.-T. Kuo, and H.-T. Chiang Ceramide Inhibits the Inwardly Rectifying Potassium Current in GH3 Lactotrophs Endocrinology, November 1, 2001; 142(11): 4785 - 4794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kleine, G. Liu, N. Leblanc, and R. L. Hebert Bradykinin stimulates ceramide production by activating specific BK-B1 receptor in rat small artery Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H175 - H183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. X. Zhang, A.-P. Zou, and P.-L. Li Ceramide Reduces Endothelium-Dependent Vasodilation by Increasing Superoxide Production in Small Bovine Coronary Arteries Circ. Res., April 27, 2001; 88(8): 824 - 831. [Abstract] [Full Text] [PDF]
|
|